Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8039 items · filings · clear filters
- 8-K - Keros Therapeutics, Inc. (0001664710) (Filer)
Automated noteKeros Therapeutics, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - FIRST UNITED CORP/MD/ (0000763907) (Filer)
Automated noteFirst United Corp filed a Form 8-K on September 29, 2026 reporting the departure, election, or appointment of directors and certain officers, and disclosing compensatory arrangements for those officers.
- 8-K - TOP Financial Group Ltd (0001848275) (Filer)
Automated noteTOP Financial Group Ltd filed a Form 8-K on September 29, 2026, reporting director/officer departures, elections, appointments and related compensation arrangements, and including its financial statements and exhibits.
- 8-K - Imunon, Inc. (0000749647) (Filer)
Automated noteImunon, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, amendments to its articles of incorporation and bylaws including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - SurgePays, Inc. (0001392694) (Filer)
Automated noteSurgePays, Inc. filed an 8-K on September 29, 2026 reporting a notice of delisting or failure to satisfy a continued listing rule and indicating a planned transfer of its listing.
- 8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)
Automated noteAllarity Therapeutics filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Bloomin' Brands, Inc. (0001546417) (Filer)
Automated noteBloomin' Brands filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - ATOSSA THERAPEUTICS, INC. (0001488039) (Filer)
Automated noteAtossa Therapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - TransDigm Group INC (0001260221) (Filer)
Automated noteTransDigm Group filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Automated noteUnicycive Therapeutics filed a Form 8-K reporting director/officer departures and appointments, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - SOUNDTHINKING, INC. (0001351636) (Filer)
Automated noteSoundThinking, Inc. filed a Form 8-K reporting a material definitive agreement, the departure and appointment of directors and officers with related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Automated noteCartesian Therapeutics filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Invivyd, Inc. (0001832038) (Filer)
Automated noteInvivyd, Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001193125-26-406007), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Automated noteAquestive Therapeutics filed a Form 8-K on September 29, 2026, reporting director/officer changes and related compensation arrangements, and including its financial statements and related exhibits.
- 8-K - JELD-WEN Holding, Inc. (0001674335) (Filer)
Automated noteJELD-WEN Holding, Inc. filed a Form 8-K on September 29, 2026, disclosing a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Automated noteIovance Biotherapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - SHERWIN WILLIAMS CO (0000089800) (Filer)
Automated noteSherwin-Williams filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation, other events, and accompanying financial statements and exhibits.
- 8-K - 1 800 FLOWERS COM INC (0001084869) (Filer)
Automated note1-800 Flowers filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.
- 8-K - Altimmune, Inc. (0001326190) (Filer)
Automated noteAltimmune, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and disclosed compensatory arrangements for those officers.
- 8-K - BeyondSpring Inc. (0001677940) (Filer)
Automated noteBeyondSpring Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Aldeyra Therapeutics, Inc. (0001341235) (Filer)
Automated noteAldeyra Therapeutics, Inc. filed an 8-K with the SEC on September 29, 2026 (Accession No. 0001193125-26-405954), including a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - CID Holdco, Inc. (0002033770) (Filer)
Automated noteCID Holdco, Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - CARMAX INC (0001170010) (Filer)
Automated noteCarMax Inc. filed an 8-K on September 29, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Immix Biopharma, Inc. (0001873835) (Filer)
Automated noteImmix Biopharma, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Atlantic Union Bankshares Corp (0000883948) (Filer)
Automated noteAtlantic Union Bankshares Corp filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - T1 Energy Inc. (0001992243) (Filer)
Automated noteT1 Energy Inc. filed an 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Alzamend Neuro, Inc. (0001677077) (Filer)
Automated noteAlzamend Neuro, Inc. filed a Form 8-K with the SEC on September 29, 2026, including a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - WESTLAKE CORP (0001262823) (Filer)
Automated noteWestlake Corp filed a Form 8-K reporting costs associated with exit or disposal activities and including a Regulation FD disclosure.
- 8-K - LIBERTY STAR URANIUM & METALS CORP. (0001172178) (Filer)
Automated noteLiberty Star Uranium & Metals Corp filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - Stewards, Inc. (0001795851) (Filer)
Automated noteStewards, Inc. filed a Form 8-K on September 29, 2026 reporting a material definitive agreement, completion of an acquisition, creation of a direct financial obligation, unregistered equity sales, and accompanying financial statements and exhibits.